Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

The Serological and Biochemical Markers of Adrenal Cortex and Endocrine Pancreas Dysfunction in Patients with Hashimoto's Thyroiditis: A Hospital-based Pilot Study.

Sahoo JP, Selviambigapathy J, Kamalanathan S, Negi VS, Sridhar MG, Kar SS, Vivekanandan M.

Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):540-544. doi: 10.4103/ijem.IJEM_72_17.

2.
3.

Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India.

Sanyal D, Majumder A, Chaudhuri SR, Chatterjee S.

Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):45-50. doi: 10.4103/2230-8210.195998.

4.

Organ-specific autoimmunity in relation to clinical characteristics in children with long-lasting type 1 diabetes.

Głowińska-Olszewska B, Michalak J, Łuczyński W, Del Pilar Larosa M, Chen S, Furmaniak J, Smith BR, Bossowski A.

J Pediatr Endocrinol Metab. 2016 Jun 1;29(6):647-56. doi: 10.1515/jpem-2015-0190.

PMID:
27008690
5.

Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity.

Moriguchi M, Noso S, Kawabata Y, Yamauchi T, Harada T, Komaki K, Babaya N, Hiromine Y, Ito H, Yamagata S, Murata K, Higashimoto T, Park C, Yamamoto A, Ohno Y, Ikegami H.

Metabolism. 2011 Jun;60(6):761-6. doi: 10.1016/j.metabol.2010.07.025. Epub 2010 Sep 9.

PMID:
20825955
6.

Effect of steroid replacement on thyroid function and thyroid autoimmunity in Addison's disease with primary hypothyroidism.

Sahoo JP, Selviambigapathy J, Kamalanathan S, Nagarajan K, Vivekanandan M.

Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):162-6. doi: 10.4103/2230-8210.176356.

7.

Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.

Silva RC, Sallorenzo C, Kater CE, Dib SA, Falorni A.

Diabetes Nutr Metab. 2003 Jun;16(3):160-8.

PMID:
14635733
8.

Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.

Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, Schicha H.

Thyroid. 2008 Jul;18(7):755-60. doi: 10.1089/thy.2008.0008.

PMID:
18631004
9.

The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease.

Penna-Martinez M, Ramos-Lopez E, Robbers I, Kahles H, Hahner S, Willenberg H, Reisch N, Seidl C, Segni M, Badenhoop K.

BMC Med Genet. 2009 Dec 4;10:126. doi: 10.1186/1471-2350-10-126.

10.

Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.

Alyafei F, Soliman A, Alkhalaf F, Sabt A, De Sanctis V, Elsayed N, Waseef R.

Acta Biomed. 2018 May 23;89(S5):32-39. doi: 10.23750/abm.v89iS4.7359.

11.

The natural course of Hashimoto's thyroiditis in children and adolescents.

Lee HS, Hwang JS.

J Pediatr Endocrinol Metab. 2014 Sep;27(9-10):807-12. doi: 10.1515/jpem-2013-0373.

PMID:
24756046
12.

Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.

Rattarasarn C, Diosdado MA, Ortego J, Leelawattana R, Soonthornpun S, Setasuban W, Jaruratanasirikul S, Patarakijvanich N.

Diabetes Res Clin Pract. 2000 Aug;49(2-3):107-11.

PMID:
10963821
13.

A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans.

Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, Herwig J, Usadel KH, Badenhoop K.

Eur J Endocrinol. 2004 Aug;151(2):193-7.

PMID:
15296474
14.

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.

PMID:
12524658
15.

Hashimoto's thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism.

Takasu N, Yoshimura Noh J.

Expert Rev Clin Immunol. 2008 Mar;4(2):221-37. doi: 10.1586/1744666X.4.2.221.

PMID:
20477052
16.

A Study of Autoimmune Polyglandular Syndrome (APS) in Patients with Type1 Diabetes Mellitus (T1DM) Followed Up at a Teritiary Care Hospital.

Shaikh SB, Haji IM, Doddamani P, Rahman M.

J Clin Diagn Res. 2014 Feb;8(2):70-2. doi: 10.7860/JCDR/2014/7013.4011. Epub 2014 Feb 3.

17.

Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies.

Kawasaki E, Abiru N, Yano M, Uotani S, Matsumoto K, Matsuo H, Yamasaki H, Yamamoto H, Yamaguchi Y, Akazawa S, et al.

J Autoimmun. 1995 Oct;8(5):633-43.

PMID:
8579720
18.

The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels among patients with euthyroid and hypothyroid goitrous and non-goitrous Hashimoto's thyroiditis versus healthy subjects.

Kilic MK, Yesilkaya Y, Tezcan K, Cinar N, Akin S, Karakaya J, Akata D, Usman A, Gurlek A.

Endocr Res. 2016 May;41(2):110-5. doi: 10.3109/07435800.2015.1094084. Epub 2016 Jan 4.

PMID:
26726836
19.

The effect of iodine restriction on thyroid function in patients with hypothyroidism due to Hashimoto's thyroiditis.

Yoon SJ, Choi SR, Kim DM, Kim JU, Kim KW, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC, Huh KB.

Yonsei Med J. 2003 Apr 30;44(2):227-35.

20.

Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.

Zwirska-Korczala K, Berdowska A, Jochem J, Sitkiewicz A, Birkner E, Polaniak R, Jedrzejowska-Szypułka H, Korzonek-Szlacheta I.

J Clin Pharm Ther. 2004 Apr;29(2):151-6.

PMID:
15068404

Supplemental Content

Support Center